Zhongding Li
Wenzhou, 325000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
USP25 inhibition ameliorates Parkinson's disease by restoring mitophagy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 07, 2026
USP25 regulates atherosclerosis by restricting RIPK1-mediated inflammatory responses.
Journal: EBioMedicine
Published: March 22, 2025
Regulation of Neuroinflammation by Microglial DUBA-IRAK1-IKKβ Signaling Loop.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 03, 2025
DUBA sustains the stability of NOD2 and RIPK2 to enhance innate immune responses.
Journal: Cell death and differentiation
Published: October 30, 2024
Deubiquitination of RIPK2 by OTUB2 augments NOD2 signalling and protective effects in intestinal inflammation.
Journal: Clinical and translational medicine
Published: May 23, 2024
OTUB1 inhibits breast cancer by non-canonically stabilizing CCN6.
Journal: Clinical and translational medicine
Published: May 22, 2023
USP25 Inhibits Neuroinflammatory Responses After Cerebral Ischemic Stroke by Deubiquitinating TAB2.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 13, 2023
USP25 inhibits renal fibrosis by regulating TGFβ-SMAD signaling pathway in Ang II-induced hypertensive mice.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: February 01, 2023
Deubiquitinating enzymes (DUBs): decipher underlying basis of neurodegenerative diseases.
Journal: Molecular psychiatry
Published: April 27, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026